Soleno Therapeutics, Inc.

$SLNO is up over 400% and leading the Nasdaq after they announced today its experimental pill helped control hunger signals in a genetic disorder that can lead to obesity

Share This Article

 

About the Author

Soleno Therapeutics, Inc.

Joey Ramson